Biotech giant Genentech, a Roche Holding subsidiary, has announced that it is laying off about 130 employees in Vacaville, California, the company’s largest U.S. manufacturing site.
The layoffs come as Genentech streamlines and restructures its business to focus on areas of growth, cutting back on production of injectables facing slow demand. The Vacaville site, established in 1994, employs approximately 1,000 people.
Roche, which has owned a majority of Genentech since 1990, agreed to purchase the biotech in 2009 for $46.8 billion.
Read the Daily Republic coverage
